These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25556149)

  • 1. Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients.
    Nangaku M; Mimura I; Yamaguchi J; Higashijima Y; Wada T; Tanaka T
    J Ren Nutr; 2015 Mar; 25(2):160-3. PubMed ID: 25556149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia.
    Tanaka T; Yamaguchi J; Higashijima Y; Nangaku M
    FASEB J; 2013 Oct; 27(10):4059-75. PubMed ID: 23792300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoxyl glucuronide, a protein-bound uremic toxin, inhibits hypoxia-inducible factor‒dependent erythropoietin expression through activation of aryl hydrocarbon receptor.
    Asai H; Hirata J; Watanabe-Akanuma M
    Biochem Biophys Res Commun; 2018 Oct; 504(2):538-544. PubMed ID: 30205954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated oxygen metabolism of the kidney by uremic toxins: review.
    Chiang CK; Tanaka T; Nangaku M
    J Ren Nutr; 2012 Jan; 22(1):77-80. PubMed ID: 22200419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner.
    Chiang CK; Tanaka T; Inagi R; Fujita T; Nangaku M
    Lab Invest; 2011 Nov; 91(11):1564-71. PubMed ID: 21863063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress.
    Palm F; Nangaku M; Fasching A; Tanaka T; Nordquist L; Hansell P; Kawakami T; Nishijima F; Fujita T
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F380-6. PubMed ID: 20519374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review.
    Hamza E; Metzinger L; Metzinger-Le Meuth V
    Cells; 2020 Sep; 9(9):. PubMed ID: 32899941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
    Yu X; Fang Y; Liu H; Zhu J; Zou J; Xu X; Jiang S; Ding X
    Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremic Advanced Glycation End Products and Protein-Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel-Like Factor 2.
    Saum K; Campos B; Celdran-Bonafonte D; Nayak L; Sangwung P; Thakar C; Roy-Chaudhury P; Owens AP
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does uremia cause vascular dysfunction?
    Brunet P; Gondouin B; Duval-Sabatier A; Dou L; Cerini C; Dignat-George F; Jourde-Chiche N; Argiles A; Burtey S
    Kidney Blood Press Res; 2011; 34(4):284-90. PubMed ID: 21691132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin.
    Farsijani NM; Liu Q; Kobayashi H; Davidoff O; Sha F; Fandrey J; Ikizler TA; O'Connor PM; Haase VH
    J Clin Invest; 2016 Apr; 126(4):1425-37. PubMed ID: 26927670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia in kidney disease: harnessing hypoxia responses for therapy.
    Koury MJ; Haase VH
    Nat Rev Nephrol; 2015 Jul; 11(7):394-410. PubMed ID: 26055355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis and treatment of anemia in chronic kidney disease].
    Nangaku M
    Rinsho Ketsueki; 2017; 58(10):1860-1863. PubMed ID: 28978825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and pathophysiology of renal erythropoietin-producing cells.
    Shih HM; Wu CJ; Lin SL
    J Formos Med Assoc; 2018 Nov; 117(11):955-963. PubMed ID: 29655605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation.
    Icardi A; Paoletti E; De Nicola L; Mazzaferro S; Russo R; Cozzolino M
    Nephrol Dial Transplant; 2013 Jul; 28(7):1672-9. PubMed ID: 23468534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.
    Tanaka T; Nangaku M
    Exp Cell Res; 2012 May; 318(9):1068-73. PubMed ID: 22414872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease.
    Iwasaki Y; Kazama JJ; Yamato H; Shimoda H; Fukagawa M
    Bone; 2013 Dec; 57(2):477-83. PubMed ID: 23920356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins.
    Hoibian E; Florens N; Koppe L; Vidal H; Soulage CO
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebro-renal interactions: impact of uremic toxins on cognitive function.
    Watanabe K; Watanabe T; Nakayama M
    Neurotoxicology; 2014 Sep; 44():184-93. PubMed ID: 25003961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.